AnodyneWiki

4-Aminopyridine

4-AP
4-Aminopyridine
Salts
[]
4-Aminopyridine hydrochloride
4-Aminopyridine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass94.11 g/mol [1]
AppearanceWhite crystals [1]
OdorOdorless [1]
Density1.2607 at 77.54 °F (USCG, 1999) - Denser than water; will sink [1]
Melting point318 °F (EPA, 1998) [1]
Boiling point524.3 °F at 760 mmHg (EPA, 1998) [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubility74 g/L [1]
Predicted LogP0.3 [1]
Structural Identifiers
[]
Molecular formulaC5H6N2
IUPAC namepyridin-4-amine
SMILESC1=CN=CC=C1N
InChIInChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)
InChIKeyNUKYPUAOHBNCPY-UHFFFAOYSA-N
CAS number504-24-5
UNIIBH3B64OKL9
PubChem CID1727
Toxicity
[]
Dog:
- oral: 3.7 mg/kg
Mouse:
- oral: 50 mg/kg
 [1]

4-Aminopyridine (also known as Fampridine, 4-Pyridinamine, Dalfampridine, 4-Pyridylamine, Avitrol, p-Aminopyridine, Ampyra, γ-Aminopyridine, Phillips 1861 or Amino-4 pyridine).

Chemistry

Salts []

4-Aminopyridine is typically found in the form of its hydrochloride salt.

 []

4-Aminopyridine is achiral.

4-Aminopyridine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

In MS, axons are progressively demyelinated which exposes potassium channels. As a result, there is a leak of potassium ions which results in the repolarization of cells and a decrease in neuronal excitability. The overall impact is the impairment of neuromuscular transmission as it is harder to trigger an action potential. Dalfampridine inhibits voltage-gated potassium channels in the CNS to maintain the transmembrane potential and prolong action potential. In other words, dalfampridine works to make sure that the current available is high enough to stimulate conduction in demyelinated axons that are exposed in MS patients. Furthermore, it facilitates neuromuscular and synaptic transmission by relieving conduction blocks in demyelinated axons. [1]

Medical side effects []

40 side effects listed on drug labels in (4-AP).

  • Urinary tract infection
  • Insomnia
  • Asthenia
  • Dizziness
  • Headache
  • Nausea
  • Back pain
  • Balance disorder
  • Nasopharyngitis
  • Paraesthesia
  • Multiple sclerosis relapse
  • Constipation
  • Dyspepsia
  • Laryngeal pain
  • Anaphylactic shock
  • Angioedema
  • Anxiety
  • Mental disorder
  • Infection
  • Confusional state
  • Feeling abnormal
  • Connective tissue disorder
  • Dyspnoea
  • Dermatitis
  • Rash
  • Gastrointestinal disorder
  • Hypersensitivity
  • Hypotension
  • Immune system disorder
  • Mediastinal disorder
  • Nervous system disorder
  • Convulsion
  • Tremor
  • Urticaria
  • Angiopathy
  • Vomiting
  • Skin disorder
  • Chest pain
  • Chest discomfort
  • Infestation

Indications

  • Multiple sclerosis
  • Walking disability

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 1727, 4-Aminopyridine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/1727
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Aminopyridine. UNII: BH3B64OKL9. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/BH3B64OKL9

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 11:00:47
drugspromissing (no DrugsPRO reagent data)2026-11-20 11:00:43
erowidmissing (no Erowid substance of that name)2026-11-20 11:00:43
gsrsok2026-11-20 11:00:44
hmdbmissing (no HMDB id)2026-11-20 11:00:43
keggok2026-11-20 11:00:45
pubchemok2026-11-20 11:00:43
redditmissing (no r/tripreports posts mention it)2026-11-20 11:00:43
siderok2026-11-20 11:00:43
structureok2026-11-20 11:00:43
wikipediaok2026-11-20 11:00:44